Advertisement
Advertisement
ABVX
Abivax SA - ADR
124.92
USDSponsored
+0.59
+0.47%
Jul 31, 15:59 UTC -4
Closed
After-Market
123.88
-1.04
-0.83%
ABVX Earnings Reports
Positive Surprise Ratio
ABVX beat 2 of 6 last estimates.
33%
Next Report
Date of Next Report
Sep 21, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.55M
/-$1.82
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+22.18%
/+14.47%
Abivax SA - ADR earnings per share and revenue
On May 25, 2026, ABVX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -1.82 USD, with revenue projected to reach 2.55 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alnylam Pharmaceuticals, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.58
Actual
$1.21
Surprise
-23.70%
Moderna, Inc. Common Stock
Report Date
Jul 31, 2026 For Q2 26
Estimate
-$2.12
Actual
-$1.97
Surprise
+7.28%
Illumina Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.38
Actual
$1.31
Surprise
-5.30%
Illumina Inc
Report Date
Jul 30, 2026 For Q1 26
Estimate
$1.25
Actual
$1.31
Surprise
+4.74%
Guardant Health, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.41
Actual
-$0.42
Surprise
-0.02%
Vericel Corporation
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.04
Surprise
+239.37%
Pharming Group N.V. ADS, each representing 10 ordinary shares
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.02
Actual
$0.00
Surprise
-90.05%
Phathom Pharmaceuticals, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.25
Actual
-$0.21
Surprise
+18.13%
Anavex Life Sciences
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.06
Surprise
+15.97%
Crescent Biopharma, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.81
Actual
-$0.74
Surprise
+8.74%
FAQ
What were Abivax SA - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Abivax SA - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Abivax SA - ADR's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Abivax SA - ADR expected to report next?
The next earning report is scheduled for Sep 21, 2026.
What are the forecasts for Abivax SA - ADR's next earnings report?
Based on --
analysts, Abivax SA - ADR is expected to report EPS of -$1.82 and revenue of $2.55M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement